Drug Profile
Research programme: obesity therapy - Servier/Tripos
Latest Information Update: 15 Apr 2010
Price :
$50
*
At a glance
- Originator Servier; Tripos
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity